Control Solutions, Inc.

Control Solutions, Inc. specializes in neuromuscular stimulation systems, primarily physical therapy devices. Their most common category is interferential stimulators, which combine electrical currents to target deeper tissues for muscle re-education, pain relief, and tissue healing. They also produce high-voltage galvanic stimulators and associated accessories like leadwire sets, power adapters, and electrode kits to complement these systems.

Control Solutions, Inc. is headquartered in the United States, which means its devices are subject to FDA regulations. Since the company’s products fall under Class II classification—requiring moderate levels of scrutiny—they must comply with FDA requirements for safety and performance, including pre-market submissions like 510(k) clearances and UDI registration. The US regulatory framework ensures these devices meet established standards for neuromuscular stimulation therapy.

Control Solutions, Inc.’s devices are listed in the FDA’s 510(k) database (for pre-market clearance submissions) and the FDA’s Unique Device Identifier (UDI) system. These registries are critical because they provide transparency on device authorizations, traceability for tracking recalls or modifications, and compliance verification for healthcare providers. Listing in these databases confirms the devices meet FDA requirements for Class II classification.

Control Solutions, Inc.’s neuromuscular stimulation systems are classified as Class II medical devices under US regulations. This classification indicates they pose moderate risks and require special controls beyond general controls (like good manufacturing practices) to ensure safety and effectiveness. For users, this means the devices undergo rigorous FDA review to validate their performance for physical therapy applications, such as pain management or muscle stimulation, while balancing accessibility and regulatory oversight.